PDCD1 and neoplasm: Even though the expression of PD-L1 is a crucial predictive factor for the treatment with PD-1/L1 blockade, many recent studies emphasize the importance of deciphering the complex interaction among several types of immune cells and tumor cells to overcome the low rate of therapeutic response.